Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
posted on
Dec 22, 2020 10:04AM
,,,incredible,,,,,,sell pressure is increasing on this so called good news,,,,,,,,,what else would we expect!!,,,,,,more likely this news will send us below our closing price from last evening. Nothing is changing other than an increase in the disrespect the investing world has for this stock and the management team behind it!